Prenumeration
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Industri |
Industri | Industriprodukter |
The agreement is for a 503(A) cleanroom suite for their new location in Gilbert, Arizona. QleanAir AB (publ), the premium provider of clean indoor environment solutions, announces an order for a new QleanSpace cleanroom from Curexa Pharmacy. The agreement value is projected at approximately USD $2,500,000. The new cleanroom suite is expected to be completed in 2024.
QleanAir is dedicated to helping its customers protect people, products, and processes through cleanrooms that meet and exceed regulatory guidelines and maintain a compliant state of control. To stay compliant with the 503(A) compounding pharmacy regulatory standards, Curexa Pharmacy has chosen QleanAir Scandinavia Inc. for their cleanroom partner. Curexa and QleanAir are already scoping Curexa’s next project, which is even larger than the first.
- “We are committed to working closely with Curexa’s pharmacy team to provide a compliant cleanroom solution that is technologically advanced and will ensure a safe environment focused on protecting products and processes necessary for compounding drugs. We are also excited to strategically strengthen our presence in the 503(A)-compounding marketplace with this partnership that also complements our successful US Hospital and Independent compounding business in the US today", says Amanda Myers, Chief Commercial Officer of QleanAir Scandinavia Inc.
- “We have been very pleased with the collaboration and work from the QleanAir team and are excited to embark on this journey with them as a trusted business partner,” says Mark Taylor, Chief Executive Officer of Curexa